Simplex Trading’s Tourmaline Bio TRML Stock Holding History

Simplex Trading’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-11	Closed	-$305	–	10096
2025 Q2	$0	Buy	+11	New	+$178	﹤0.01%	9750
2024 Q3	–	Sell	-104	Closed	-$1.74K	–	9607
2024 Q2	$1K	Sell	104 -1,914	-95%	-$30.8K	﹤0.01%	8578
2024 Q1	$46K	Buy	+2,018	New	+$71.2K	﹤0.01%	6344

Simplex Trading's TRML Position: Q3 2025 in Review

Simplex Trading sold out of Tourmaline Bio (TRML) in Q3 2025, closing a stake of 11 shares — an estimated $305 sold.

Simplex Trading first reported a position in TRML in Q1 2024 and held it in 3 quarters. The position peaked at $46K in Q1 2024. 134 funds tracked by Wall St. Rank hold TRML as of Q3 2025.

Simplex Trading reported no remaining Tourmaline Bio position as of Q3 2025 after selling out during the quarter.
Simplex Trading sold 11 Tourmaline Bio shares in Q3 2025, an estimated $305.
Simplex Trading first reported a position in Tourmaline Bio in Q1 2024 and held it in 3 quarters.
Simplex Trading's Tourmaline Bio position peaked at $46K in Q1 2024.
134 funds tracked by Wall St. Rank held Tourmaline Bio as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.